The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
November 24th 2024
Data show that a child’s insurance status is independently associated with mortality after hematopoietic cell transplantation.
Kidney Transplant Provides Greater Benefit Than Long-Term Dialysis for Patients With Kidney Failure
October 11th 2022Although survival benefits for patients who received a kidney transplant varied, the benefits of kidney transplants were greater for all patients when compared with long-term dialysis.
Read More
FDA Approves Furosemide Injection for Congestion in Patients with Chronic Heart Failure
October 10th 2022Furosemide injection 80 mg/10 mL (Furoscix; scPharmaceuticals) is indicated for the at-home treatment of congestion caused by fluid overload in adult patients with New York Heart Association Class II/III chronic heart failure.
Read More
Trends in Behavioral and Mental Health Treatment Since the Start of the Pandemic
October 10th 2022New research finds that mental health has replaced COVID-19 as the top health concern among Americans, but deeper analysis needs to be done into whether depression and anxiety are truly becoming more widespread.
Read More
Pharmacist Insights: Descovy and Truvada for HIV Pre-Exposure Prophylaxis
October 10th 2022Clinical studies have shown similar efficacy between emtricitabine and tenofovir alafenamide (Descovy) and emtricitabine and tenofovir disoproxil fumarate (Truvada) for individuals at risk for HIV infection.
Watch
Monkeypox Treatment and Prevention: Stopping the Latest Outbreak
There is not yet an FDA-approved treatment available for monkeypox, but existing antiviral agents have been found to be effective in vitro and in animal studies.
Read More
Acetazolamide Found to Improve Decongestion in Patients With Acute Decompensated Heart Failure
October 7th 2022New research suggests that acetazolamide and standard loop-diuretic therapy may decrease congestion and prevent future hospitalizations in patients with acute decompensated heart failure.
Read More
Dostarlimab Plus Chemotherapy Shows Promise in Non-Small Cell Lung Cancer
October 6th 2022Results from the largest head-to-head trial of programmed death receptor-1 inhibitors suggest that dostarlimab and chemotherapy could be an effective treatment option for patients with metastatic non-squamous non-small cell lung cancer.
Read More